These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25652322)

  • 41. Gastrointestinal stem cells. I. Pancreatic stem cells.
    Soria B; Bedoya FJ; Martin F
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G177-80. PubMed ID: 16014979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of animal models to study stem cell therapies for diabetes mellitus.
    Song WJ; Shah R; Hussain MA
    ILAR J; 2009; 51(1):74-81. PubMed ID: 20075499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
    Limbert C; Päth G; Jakob F; Seufert J
    Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular pathways to beta-cell replacement.
    Fellous TG; Guppy NJ; Brittan M; Alison MR
    Diabetes Metab Res Rev; 2007 Feb; 23(2):87-99. PubMed ID: 17048266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo.
    Rezania A; Bruin JE; Xu J; Narayan K; Fox JK; O'Neil JJ; Kieffer TJ
    Stem Cells; 2013 Nov; 31(11):2432-42. PubMed ID: 23897760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of insulin-producing islet-like clusters from human embryonic stem cells.
    Jiang J; Au M; Lu K; Eshpeter A; Korbutt G; Fisk G; Majumdar AS
    Stem Cells; 2007 Aug; 25(8):1940-53. PubMed ID: 17510217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Embryonic stem cell-based diabetes therapy--a long road to travel.
    Serup P
    Diabetologia; 2006 Nov; 49(11):2537-40. PubMed ID: 17019597
    [No Abstract]   [Full Text] [Related]  

  • 48. Regenerative medicine in diabetes.
    Matveyenko A; Vella A
    Mayo Clin Proc; 2015 Apr; 90(4):546-54. PubMed ID: 25841258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stem cell and gene therapies for diabetes mellitus.
    Calne RY; Gan SU; Lee KO
    Nat Rev Endocrinol; 2010 Mar; 6(3):173-7. PubMed ID: 20173779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prospect of induced pluripotent stem cells for diabetes mellitus treatment.
    Soejitno A; Prayudi PK
    Ther Adv Endocrinol Metab; 2011 Oct; 2(5):197-210. PubMed ID: 23148185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-Producing Cell Transplantation Platform for Veterinary Practice.
    Kuncorojakti S; Srisuwatanasagul S; Kradangnga K; Sawangmake C
    Front Vet Sci; 2020; 7():4. PubMed ID: 32118053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An interview with Doug Melton.
    Maartens A
    Development; 2016 Dec; 143(24):4555-4557. PubMed ID: 27965436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regenerative Medicine and Diabetes: Targeting the Extracellular Matrix Beyond the Stem Cell Approach and Encapsulation Technology.
    Peloso A; Citro A; Zoro T; Cobianchi L; Kahler-Quesada A; Bianchi CM; Andres A; Berishvili E; Piemonti L; Berney T; Toso C; Oldani G
    Front Endocrinol (Lausanne); 2018; 9():445. PubMed ID: 30233489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Stem cells in diabetes treatment].
    Heinis M; Duvillié B
    Ann Endocrinol (Paris); 2008 Apr; 69(2):143-6. PubMed ID: 18420179
    [No Abstract]   [Full Text] [Related]  

  • 55. Location matters for insulin-producing cells.
    Spagnoli FM
    Nature; 2018 Dec; 564(7734):50-51. PubMed ID: 30510228
    [No Abstract]   [Full Text] [Related]  

  • 56. Coculture of insulin-producing RIN5AH cells with neural crest stem cells protects partially against cytokine-induced cell death.
    Ngamjariyawat A; Turpaev K; Welsh N; Kozlova EN
    Pancreas; 2012 Apr; 41(3):490-2. PubMed ID: 22415669
    [No Abstract]   [Full Text] [Related]  

  • 57. Toward beta cell replacement for diabetes.
    Johannesson B; Sui L; Freytes DO; Creusot RJ; Egli D
    EMBO J; 2015 Apr; 34(7):841-55. PubMed ID: 25733347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells.
    Toyoda T; Mae S; Tanaka H; Kondo Y; Funato M; Hosokawa Y; Sudo T; Kawaguchi Y; Osafune K
    Stem Cell Res; 2015 Mar; 14(2):185-97. PubMed ID: 25665923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice.
    Vegas AJ; Veiseh O; Gürtler M; Millman JR; Pagliuca FW; Bader AR; Doloff JC; Li J; Chen M; Olejnik K; Tam HH; Jhunjhunwala S; Langan E; Aresta-Dasilva S; Gandham S; McGarrigle JJ; Bochenek MA; Hollister-Lock J; Oberholzer J; Greiner DL; Weir GC; Melton DA; Langer R; Anderson DG
    Nat Med; 2016 Mar; 22(3):306-11. PubMed ID: 26808346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Human Endocrine Pancreas: New Insights on Replacement and Regeneration.
    Domínguez-Bendala J; Lanzoni G; Klein D; Álvarez-Cubela S; Pastori RL
    Trends Endocrinol Metab; 2016 Mar; 27(3):153-162. PubMed ID: 26774512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.